MECP2 / Methyl-CpG-binding protein 2 · IHC design guide

Design Immunohistochemistry for MECP2

Plan MECP2 paraffin-section IHC around nuclear staining across tissues (HPA tissue IHC). Use the cell-type differences reported in tissue sections to guide interpretation (HPA tissue IHC).

Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use

Immunohistochemistry protocol sheet for MECP2 (IHC for MECP2): expected localisation Nuclear staining across tissues (HPA tissue IHC), antibody A00047-1, validated IHC image, and IHC protocol steps — Printable **MECP2** IHC protocol sheet — expected localisation Nuclear staining across tissues (HPA tissue IHC), antibody A00047-1, controls and protocol steps. Open the full MECP2 IHC guide →

Navigate to: Protocols Staining pattern Controls Antibodies

MECP2 Immunohistochemistry Experimental Design Guide

Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before staining

	Expected localisation	Nuclear staining across tissues (HPA tissue IHC)
	Staining pattern	Nuclear staining in cells across all tissues (HPA tissue IHC)
	Antigen retrieval	EDTA pH 8.0 HIER, heat-mediated (datasheet A00047-1)
	Positive control ⓘ	Adrenal gland+4 more · see all
	Negative control ⓘ	None in HPA (detected in all 45 tissues); use no-primary + isotype controls

Important caveats

Reasons your staining may differ from the expected pattern.

	Fixation	Keep fixation consistent across sections (standard IHC practice; not target-specific)
	Caveat	Low staining in oral squamous and rectal endothelial cells (HPA tissue IHC)
	Regulation	Broad adult somatic expression (UniProt)
	Isoform / epitope	Two isoforms, A and B; verify epitope coverage (UniProt)

Section 1

Recommended MECP2 IHC & IF Protocols

The catalog antibody’s IHC-P protocol uses EDTA pH 8.0 retrieval (datasheet: A00047-1). The published protocols below report citrate retrieval in paraffin sections (PMC2916867; PMC12971181; PMC4564377).

Recommended immunohistochemistry (IHC-P) protocol parameters
Sample	Paraffin-embedded mouse brain tissue; fixative not specified (datasheet A00047-1)
Fixation	Image fixative and duration unreported (datasheet A00047-1); verify before use.
Sectioning	4–5 µm sections on charged slides (standard)
Deparaffinisation	Xylene, graded ethanol series to water (standard)
Antigen retrieval	Heat retrieval: EDTA pH 8.0 (datasheet A00047-1); 20 min, 95–100 °C (standard)
Peroxidase block	3% H2O2, 10 min, room temperature (standard)
Blocking	10% goat serum (datasheet A00047-1)
Primary antibody	Rabbit anti-MECP2, 2-5 μg/ml (datasheet A00047-1)
Primary incubation	Overnight at 4 °C (datasheet A00047-1)
Detection	HRP-conjugated secondary, DAB chromogen (datasheet A00047-1)
Counterstain	Hematoxylin, blue, dehydrate and mount (standard)
Expected result	MECP2-positive staining in glandular cells of adrenal gland (HPA tissue IHC: High). HPA tissue profile: Nuclear expression in all tissues. No signal in the no-primary control.

💡Decision noteStart with EDTA pH 8.0 for the catalog antibody (datasheet: A00047-1). If adapting a published antibody protocol, test its reported citrate retrieval separately (PMC2916867; PMC12971181; PMC4564377).

Section 2

What Is the Expected MECP2 Staining Pattern?

MECP2 should stain nuclei across adult somatic tissues (UniProt P51608: tissue specificity; HPA: nuclear expression in all tissues). HPA reports high staining in selected glandular, hematopoietic and neural cell populations, with low staining in some others (HPA: tissue IHC). Its nuclear location and lack of a transmembrane segment support a nuclear interpretation (UniProt P51608: subcellular location and topology). The tissue IHC profile has Enhanced reliability (HPA: tissue IHC).

What am I looking at on my slide?
Distinct nuclear chromogen in the expected cells, with visible counterstained tissue structure.	This fits MECP2 localisation (UniProt P51608: nucleus; HPA: nuclear expression in all tissues). Judge intensity against the same tissue and cell population in HPA; high examples include adrenal glandular cells and bone marrow hematopoietic cells (HPA: tissue IHC).
Predominantly cytoplasmic or membranous staining while nuclei remain clear.	This conflicts with the reported nuclear pattern (UniProt P51608: nucleus; HPA: tissue IHC). Review morphology, detection controls and antibody specificity before scoring it as MECP2 (general IHC practice).
Strong staining is concentrated in an unexpected cell population.	Consider cross-reactivity or endogenous detection activity (general IHC practice). HPA reports low staining in oral squamous epithelial cells and rectal endothelial cells, but supplies no negative tissue list; low staining is not evidence of absence (HPA: tissue IHC).
Chromogen spreads across nuclei and surrounding tissue without clear cell boundaries.	This is difficult to score as nuclear MECP2 (HPA: tissue IHC). Diffuse background can arise from nonspecific binding or detection activity; compare a no-primary control and assess whether the deposit follows tissue structures (general IHC practice).
No nuclear signal appears in a tissue expected to stain strongly.	Check assay performance before calling the specimen negative. Adrenal glandular cells and breast glandular cells are reported high (HPA: tissue IHC); absent signal there warrants review of section quality, antibody use and detection controls (general IHC practice).

💡Expected MECP2 appearanceA convincing positive is nuclear chromogen in the relevant cells, with high signal in HPA high populations such as adrenal glandular cells; dominant cytoplasmic colour or strong staining confined to an unexpected population is suspect (HPA: tissue IHC; UniProt P51608: nucleus; general IHC practice).

How each factor affects the staining
Tissue and cell population	HPA reports nuclear expression in all tissues, yet intensity varies by population: high in cerebral cortex glial cells and cerebellar Bergmann glia, low in oral squamous epithelial cells and rectal endothelial cells (HPA: tissue IHC). Compare like with like when scoring.
Antibody evidence	The tissue profile is Enhanced (HPA: tissue IHC). HPA000593 and HPA001341 have Enhanced IHC validation; CAB037264 is Supported (HPA: antibody validation). Those labels support their reported patterns but do not validate an unspecified catalog antibody.
Antigen retrieval	Use the chosen IHC-P antibody's documented conditions and assess optimisation with a known-positive tissue and controls (general IHC practice). The supplied UniProt and HPA records do not report MECP2-specific retrieval or fixation sensitivity.
Isoforms and epitope	UniProt lists 2 MECP2 isoforms, A and B, and an MBD at residues 90–162 (UniProt P51608: isoforms and domains). The supplied sources do not locate the catalog antibody's epitope, so they cannot establish which isoforms it detects.
IF/ICC Q&A: should localisation agree?	Yes: HPA reports approved nucleoplasmic localisation in ICC-IF, while UniProt places MECP2 in the nucleus (HPA: subcellular; UniProt P51608: location). HPA000593 has Supported ICC validation (HPA: antibody validation); consult the separate IF/ICC guide for that application.

Why is my staining missing, weak or wrong?
Situation	Likely cause	Next action
Known-positive tissue has no nuclear staining.	An assay or section problem is possible; the observation conflicts with HPA high staining in adrenal or breast glandular cells (HPA: tissue IHC).	Verify the positive-control section, antibody and detection steps, then repeat with the chosen antibody's documented IHC-P conditions (general IHC practice). Do not infer MECP2 loss from one failed control.
Signal is mainly cytoplasmic or outlines cell membranes.	That distribution conflicts with nuclear MECP2 and its lack of a transmembrane segment (UniProt P51608: location and topology; HPA: tissue IHC).	Review nuclear morphology and the no-primary control; reassess antibody specificity before treating the colour as a positive result (general IHC practice).
A cell population expected to stain weakly appears intensely positive.	Nonspecific antibody binding or endogenous detection activity is possible (general IHC practice). HPA records low staining in oral squamous epithelial cells and rectal endothelial cells (HPA: tissue IHC).	Compare the same cell type in the HPA profile, inspect a no-primary control and, where available, compare an independently validated IHC antibody (HPA: antibody validation; general IHC practice).
Chromogen is diffuse across the section.	Nonspecific binding or endogenous detection activity may obscure a nuclear pattern (general IHC practice; HPA: tissue IHC nuclear profile).	Check the no-primary control, blocking and wash steps; score MECP2 only where individual nuclei can be distinguished from surrounding background (general IHC practice).
Only a few cells stain in a broadly positive tissue.	Cell-type composition and staining intensity vary: HPA reports both high and low populations, despite nuclear expression across tissues (HPA: tissue IHC).	Identify the stained cell population before scoring. Compare it with the corresponding HPA tissue entry and a positive-control section processed alongside it (HPA: tissue IHC; general IHC practice).
Counterstain makes a weak brown nuclear signal hard to judge.	Overlapping nuclear colours can make chromogenic localisation difficult to read (general IHC practice).	Compare with the no-primary control and assess chromogen and counterstain balance using the laboratory's standard IHC controls; call a positive only when nuclear chromogen is discernible (general IHC practice; HPA: nuclear expression).

Source: UniProt P51608 Human Protein Atlas tissue Human Protein Atlas subcellular

Experiment evidence

IHC & IF images showing MECP2 staining

IHC analysis of MECP2 using anti-MECP2 antibody (A00047-1). MECP2 was detected in a paraffin-embedded section of mouse brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 μg/ml rabbit anti-MECP2 Antibody (A00047-1) overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB as the chromogen.

A00047-1 · IHCIHC analysis of MECP2 using anti-MECP2 antibody (A00047-1). MECP2 was detected in a paraffin-embedded section of mouse brain tissue. Heat me

IF analysis of MECP2 using anti-MECP2 antibody (A00047-1). MECP2 was detected in a paraffin-embedded section of mouse brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 5 μg/mL rabbit anti-MECP2 Antibody (A00047-1) overnight at 4°C. Cy3 Conjugated Goat Anti-Rabbit IgG (BA1032) was used as secondary antibody at 1:500 dilution and incubated for 30 minutes at 37°C. The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.

A00047-1 · IFIF analysis of MECP2 using anti-MECP2 antibody (A00047-1). MECP2 was detected in a paraffin-embedded section of mouse brain tissue. Heat med

HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000169057-MECP2/tissue/cerebral+cortex#imid_195554

HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000169057-MECP2/tissue/colon#imid_210736

HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000169057-MECP2/tissue/liver#imid_210745

HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000169057-MECP2/tissue/kidney#imid_210746

HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA000593; green = MECP2, blue = nucleus, red = microtubules.

← swipe / scroll for more images →

Real IHC / IF data behind the staining-pattern expectations in this section.

Sample controls for MECP2 IHC & IF

🧪Run bone marrow first: hematopoietic cells should show nuclear MECP2 staining (HPA: High in bone marrow hematopoietic cells; UniProt P51608: nucleus). HPA detects MECP2 in all 45 scored tissues, so there is no listed negative tissue; use no-primary and isotype controls, and expect mature, enucleated erythrocytes on the slide, if present, to lack nuclear staining (HPA: no negative rows; standard IHC practice).

Positive control tissue: Adrenal gland (Glandular cells, HPA High)

Negative control tissue: None in HPA: MECP2 is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead.

ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show MECP2 in A-431, U-251MG, U2OS, with annotated localisation: Nucleoplasm (approved) (HPA subcellular).

Technical controls: Include a no-primary, secondary-only control; an isotype control matched to the primary antibody’s host species and clonality; and MECP2-knockout tissue as a biological negative (standard IHC practice). Block endogenous peroxidase and assess residual background in bone marrow, where hematopoietic cells can contribute peroxidase activity (standard chromogenic IHC practice).

⚠️Feasibility: No target-specific fixation window or fixation effect is reported in the supplied evidence, and the selected A00047-1 paraffin-section caption does not state the fixative (selected tissue-IHC caption: fixative unreported). That caption reports heat-mediated retrieval in EDTA at pH 8.0 for mouse brain, so retrieval is a supported starting point that needs checking in bone marrow (selected tissue-IHC caption). The evidence does not establish whether frozen sections or IF are easier for MECP2; ICC-IF images show nucleoplasmic localization, and IF/ICC guidance belongs on its separate page (HPA: nucleoplasm, approved).

HPA tissue IHC evidence for MECP2

Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue	Cell type	Level	Evidence	Source
Adrenal gland	Glandular cells	High	Protein (IHC)	HPA →
Appendix	Non-germinal center cells	High	Protein (IHC)	HPA →
Bone marrow	Hematopoietic cells	High	Protein (IHC)	HPA →
Breast	Glandular cells	High	Protein (IHC)	HPA →
Bronchus	Respiratory epithelial cells	High	Protein (IHC)	HPA →

Undetected expression · recommended negative controls

Tissue	Cell type	Level	Evidence	Source
None in HPA: MECP2 is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead.

Section 3

Advanced MECP2 IHC Tips

Troubleshoot MECP2 staining in paraffin sections by checking nuclear localisation, retrieval, controls, and cell-level scoring (UniProt P51608; HPA tissue IHC).

Which retrieval conditions should I try when MECP2 nuclear staining is weak?

Start with heat-mediated antigen retrieval in EDTA at pH 8.0 (datasheet A00047-1). The selected paraffin-section image used that retrieval before overnight primary incubation at 4°C (datasheet A00047-1), so use it as the first comparison condition. If staining remains weak, compare a second retrieval condition on adjacent sections while keeping antibody concentration, detection, and imaging constant (standard IHC practice). Score nuclear signal against tissue background and include a no-primary control, because MECP2 is nuclear (UniProt P51608) and widespread nuclear staining has been observed across tissues (HPA tissue IHC).

How should I handle variable fixation when MECP2 staining differs between sections?

The selected caption identifies a paraffin-embedded mouse brain section but does not state its fixative or fixation duration (datasheet A00047-1). Target-specific sensitivity to fixation is therefore unknown from the supplied evidence; do not assign weak MECP2 staining to a particular fixative without a controlled comparison (datasheet A00047-1). Record the fixative, time to fixation, duration, section thickness, and processing history for each specimen, then compare sections processed together (standard IHC practice). Keep EDTA retrieval at pH 8.0 and the 2 μg/ml primary concentration constant during that comparison (datasheet A00047-1).

What staining pattern should count as correctly localised MECP2?

Score convincing MECP2 signal within nuclei, since MECP2 is a nuclear chromosomal protein associated with methylated DNA (UniProt P51608). Nucleoplasmic localisation is supported by cell imaging (HPA subcellular), while localisation with methyl-CpG and TBL1X at heterochromatin foci is reported separately (UniProt P51608). The tissue IHC profile reports nuclear expression across tissues, including high staining in cerebral-cortex and caudate glial cells (HPA tissue IHC). Examine a nuclear counterstain alongside DAB at the same magnification, and investigate diffuse cytoplasmic staining or section-wide haze with a no-primary control before scoring cells positive (standard IHC practice; UniProt P51608 localisation).

Could isoforms or epitope accessibility explain discordant MECP2 staining?

MECP2 has 2 listed isoforms, A and B, and a methyl-CpG-binding domain spanning residues 90–162 (UniProt P51608). Its listed modified residues include phosphoserines at 13, 80, and 116, plus methylarginine at 162 (UniProt P51608); the payload does not identify the catalog antibody’s epitope (datasheet A00047-1). Check its immunogen or epitope documentation before interpreting a missing signal as isoform absence, and compare antibody results only where their recognised sequences are established (standard IHC practice). Assess retrieval and nuclear counterstaining in matched sections, since inaccessible epitopes can produce weak staining without establishing which MECP2 isoform is present (standard IHC practice).

How should I adapt this nuclear MECP2 assay for multiplex IF?

Treat multiplex IF as a separate assay: the selected catalog evidence documents chromogenic IHC in a paraffin section, with no IF protocol in the supplied caption (datasheet A00047-1). Pair MECP2 with a validated marker for the expected cell population, such as a glial marker when examining cerebral cortex or caudate glia, and require nuclear MECP2 signal within marker-defined cells (HPA tissue IHC; UniProt P51608 localisation). Choose fluorophores after inspecting unstained tissue for autofluorescence, and use single-label controls to check spectral bleed-through (standard IF practice). Because MECP2 is nuclear and has no transmembrane segment (UniProt P51608), optimise permeabilisation for nuclear antibody access rather than for a membrane-facing epitope (standard IF practice).

How can I reduce diffuse brown background without losing nuclear signal?

The selected assay used 10% goat serum blocking, 2 μg/ml primary antibody overnight at 4°C, and a peroxidase-linked secondary for 30 minutes at 37°C (datasheet A00047-1). If brown signal spreads beyond nuclei, compare a no-primary control and inspect tissue edges before changing the antibody concentration (standard IHC practice; UniProt P51608 localisation). Apply a peroxidase block and control DAB development time as general chromogenic IHC steps, particularly when background also appears in the no-primary section (standard IHC practice). Optimise washes and detection exposure on matched sections while retaining interpretable nuclear staining as the readout (standard IHC practice; HPA tissue IHC).

What is a defensible way to quantify MECP2 IHC across specimens? ⚠ ANSWER MARKED FOR VERIFICATION

Define the scored compartment as the nucleus before counting, consistent with the reported MECP2 localisation and tissue staining profile (UniProt P51608; HPA tissue IHC). In matched regions, report the percentage of positive nuclei and, if intensity is reproducible, an H-score using 0–3 nuclear intensity categories (standard IHC practice). Alternatively, report positive-nucleus density per mm² when cell density itself is relevant, alongside the total nuclei counted (standard IHC practice). Normalise positive counts to all eligible nuclei in the same annotated cell population, apply one threshold and imaging setup throughout, and exclude folds or damaged areas by a preset rule (standard IHC practice).

How do I distinguish genuine MECP2 staining from section artefacts?

A credible positive shows nuclear staining in intact cells, consistent with MECP2’s nuclear localisation and the broadly nuclear tissue IHC profile (UniProt P51608; HPA tissue IHC). Compare cell identity with the sampled region: high staining is reported in cerebral-cortex glial cells and cerebellar Bergmann glia nuclei, while low staining is reported in oral-mucosa squamous epithelial cells (HPA tissue IHC). Treat predominant cytoplasmic signal, sharp edge-only staining, and staining over necrotic or detached material as suspect until controls resolve them (standard IHC practice; UniProt P51608 localisation). Check a no-primary section for endogenous peroxidase or detection background before calling unexpected DAB deposits MECP2 positive (standard IHC practice).

Boster reagents

Best MECP2 / Methyl-CpG-binding protein 2 IHC Antibodies

The catalog documents MECP2 staining in paraffin sections of human, mouse and rat tissue, plus IF in mouse and rat brain sections and A431 cells (catalog image captions).

Real IHC data

Anti-MECP2 Antibody ®

Cat # A00047-1

View product →

The rendered A00047-1 card shows IHC in mouse brain paraffin sections and the catalog also documents rat brain IHC and mouse and rat brain IF (A00047-1 image captions). A00047 provides additional catalog evidence for IHC in human colon cancer, human mammary cancer, mouse brain and rat brain paraffin sections, and ICC/IF in A431 cells (A00047 image captions).

Which to pick: For mouse or rat brain paraffin IHC, choose A00047-1 if its EDTA retrieval at pH 8.0 suits the assay; its IHC caption uses 2 μg/ml primary antibody, and the fixative is unreported (A00047-1 IHC image caption). For human tissue IHC or A431 ICC/IF, choose A00047 because those preparations have corresponding images; its tissue IHC captions use citrate retrieval at pH 6 for 20 minutes, with fixative unreported (A00047 image captions). A00047-1 lists monkey reactivity, but neither a monkey IHC image nor clonality is reported, so confirm performance in the intended sample (A00047-1 catalog payload).

Each figure is that product's own IHC / IF validation image from its datasheet.

References

UniProt Consortium. UniProt entry P51608 (MECP2_HUMAN, Methyl-CpG-binding protein 2).
Human Protein Atlas. MECP2 tissue IHC expression (reliability: Enhanced).
Human Protein Atlas. MECP2 subcellular location (ICC-IF): Localized to the nucleoplasm..
Human Protein Atlas. MECP2 antibody validation summary (3 antibodies).
Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin. Scientific reports 2021 — PMC8290043.
Ocular MECP2 protein expression in patients with and without Rett syndrome. Pediatric neurology 2010 — PMC2916867.
Role of MeCP2 in Shaping the Histopathological Heterogeneity of Ampullary Carcinoma. Acta histochemica et cytochemica 2026 — PMC12971181.
Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory. Acta histochemica et cytochemica 2015 — PMC4564377.
PubMed PMID:9710633 — UniProt-cited evidence.
PubMed PMID:8976388 — UniProt-cited evidence.
PubMed PMID:10369871 — UniProt-cited evidence.